Ledger.Open graph →
SEC Form D · filed November 10, 2022

TriSalus Life Sciences, Inc

Offering
$81.4M
Sold
$81.4M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WESTMINSTER, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Simone Song · Westminster, CODirectorJohn L. Tullis · Westminster, CODirectorRaj L. Mistry · Westminster, COExecMats L. Wahlstrom · WESTMINSTER, CODirectorAnil Singhal · WESTMINSTER, CODirectorGene Mcgrevin · WESTMINSTER, CODirectorDiane Parks · Westminster, CODirectorSean Murphy · Westminster, COExec · DirectorKerry Hicks · Westminster, CODirectorMary T. Szela · Westminster, COExec · DirectorDean D. Varner · TAMPA, FLDirectorElisabeth Cullington · Bend, ORExec · DirectorChristopher T. Ladd · Bentonville, ARDirectorEva Maglis · Toronto, Ontario, CanadaExec · DirectorKyle J. Charters · Durham, NCDirectorStefan T. Sterns · Bentonville, ARDirectorKelly Ortiz · OAKBROOK TERRACE, ILExecShaun Madden · Bend, ORDirectorS. James Miller Jr · Bend, ORDirectorMark A. Buis · Southfield, MIDirectorMark Mccurdy, M.D · Fort Worth, TXExec · DirectorAjith Pai · Fort Worth, TXDirectorJulie Elsey · Fort Worth, TXDirectorWilliam Crawford · Fort Worth, TXDirectorRebecca Tucker · Fort Worth, TXDirectorBrett Truka · Chula Vista, CAExec · DirectorNehemiah R. Stewart · Chapel Hill, NCDirectorZachary D. Schrank · Chapel Hill, NCDirectorSignalfire Xir Venture Fund Ii GP, L.L.C · SAN FRANCISCO, CADirectorSze Chyi G. Lim · Singapore, U0Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗